C84.02
Mycosis fungoides, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Mycosis Fungoides is a rare type of skin lymphoma, which is a cancer that begins in certain cells of the immune system called T lymphocytes or T cells. When it involves the lymph nodes within the chest, known as intrathoracic lymph nodes, it indicates a progression of the disease. Though it is a slow-growing cancer in its early stages, it can become more aggressive over time, impacting the skin and lymphatic system. Recognizing the characteristics and understanding the implications of this condition can help in managing it effectively.
Causes & Symptoms
Clinical Causes: The precise cause of mycosis fungoides remains unknown, but it involves abnormal T lymphocytes. Genetic mutations may play a role in the development of the disease. Environmental factors, such as exposure to certain chemicals or radiation, have been explored but are not definitively linked. The disease is not contagious; it does not spread through casual contact.
Key Symptoms: Persistent skin patches that may be scaly, reddish, or brownish in appearance. Itchy skin, often severe and persistent. Progression to thicker skin areas or plaques and nodules. Lymphadenopathy, particularly swelling of chest lymph nodes. Possible symptoms related to symptoms from lymph node involvement, such as chest discomfort or unexplained coughs. Less commonly, systemic symptoms like fatigue, fever, or weight loss may occur in advanced stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosing mycosis fungoides with intrathoracic lymph node involvement involves a combination of examinations and tests:
Treatment Protocols: Treatment approaches are tailored to the extent of the disease, its stage, and individual patient factors:
Clinical Advice & FAQs
Billing Guidance
Is C84.02 a billable ICD-10 code?
Yes, C84.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.02?
Clinical documentation must specify the nature of Mycosis fungoides, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference